Farrell PJ - Search Results

1

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T. Gasco M, et al. Among authors: farrell pj. Oncogene. 2002 Mar 14;21(12):1876-81. doi: 10.1038/sj.onc.1205256. Oncogene. 2002. PMID: 11896620

2

Concomitant inactivation of p53 and Chk2 in breast cancer.

Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T. Sullivan A, et al. Among authors: farrell pj. Oncogene. 2002 Feb 21;21(9):1316-24. doi: 10.1038/sj.onc.1205207. Oncogene. 2002. PMID: 11857075

3

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ, Tavassoli M, Gusterson B, Crook T. Gasco M, et al. Among authors: farrell pj. Cancer Res. 2002 Apr 1;62(7):2072-6. Cancer Res. 2002. PMID: 11929827

4

p73 is over-expressed in vulval cancer principally as the Delta 2 isoform.

O'Nions J, Brooks LA, Sullivan A, Bell A, Dunne B, Rozycka M, Reddy A, Tidy JA, Evans D, Farrell PJ, Evans A, Gasco M, Gusterson B, Crook T. O'Nions J, et al. Among authors: farrell pj. Br J Cancer. 2001 Nov 16;85(10):1551-6. doi: 10.1054/bjoc.2001.2138. Br J Cancer. 2001. PMID: 11720444 Free PMC article.

5

Analysis of CHK2 in vulval neoplasia.

Reddy A, Yuille M, Sullivan A, Repellin C, Bell A, Tidy JA, Evans DJ, Farrell PJ, Gusterson B, Gasco M, Crook T. Reddy A, et al. Among authors: farrell pj. Br J Cancer. 2002 Mar 4;86(5):756-60. doi: 10.1038/sj.bjc.6600131. Br J Cancer. 2002. PMID: 11875739 Free PMC article.

6

Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus.

Brooks LA, Tidy JA, Gusterson B, Hiller L, O'Nions J, Gasco M, Marin MC, Farrell PJ, Kaelin WG Jr, Crook T. Brooks LA, et al. Among authors: farrell pj. Cancer Res. 2000 Dec 15;60(24):6875-7. Cancer Res. 2000. PMID: 11156383

7

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. Sullivan A, et al. Among authors: farrell pj. Oncogene. 2004 Apr 22;23(19):3328-37. doi: 10.1038/sj.onc.1207428. Oncogene. 2004. PMID: 15077186

8

E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia.

Brooks LA, Sullivan A, O'Nions J, Bell A, Dunne B, Tidy JA, Evans DJ, Osin P, Vousden KH, Gusterson B, Farrell PJ, Storey A, Gasco M, Sakai T, Crook T. Brooks LA, et al. Among authors: farrell pj. Br J Cancer. 2002 Jan 21;86(2):263-8. doi: 10.1038/sj.bjc.6600033. Br J Cancer. 2002. PMID: 11870517 Free PMC article.

9

Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.

Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, Allday MJ. Parker GA, et al. Among authors: farrell pj. Oncogene. 1996 Dec 19;13(12):2541-9. Oncogene. 1996. PMID: 9000128

10

Relation between infection with a subtype of HPV16 and cervical neoplasia.

Tidy JA, Vousden KH, Farrell PJ. Tidy JA, et al. Among authors: farrell pj. Lancet. 1989 Jun 3;1(8649):1225-7. doi: 10.1016/s0140-6736(89)92329-5. Lancet. 1989. Retraction in: Lancet. 1989 Dec 23-30;2(8678-8679):1535. doi: 10.1016/s0140-6736(89)92987-5 PMID: 2566780 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters